Schülke & Mayr GmbH   Report issue

For profit Phase 4
Founded: Norderstedt Germany (1889)
Status: Acquired by Air Liquide (1996)

Organization Overview

First Clinical Trial
2011
NCT01434914
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Schülke & Mayr GmbH

Active Ingredients

Drugs in Phase 4 Trials (2)

octenidine (4 trials)

phenoxyethyl alcohol (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Foot Ulcer (Phase 4)

Gingivitis (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 2